Therapy News and Research

RSS

OCCAM Immune and Cancer Research Institute join forces to advance immunotherapy

In a new collaboration that could transform how cancer is treated, OCCAM Immune-a Mount Sinai initiative focused on understanding the immune system's role in disease-is partnering with the Cancer Research Institute (CRI) to unlock the secrets of how the immune system responds to advanced therapies.

17 Jun 2025

Colorectal cancer patients fare better when diagnosed before other cancers

A new study using one of the world's largest cancer registries shows that patient outcomes can be significantly impacted depending on when colorectal cancer (CRC) is diagnosed related to other cancers.

17 Jun 2025

Aquatic therapy eases back pain and boosts mental health

A new Concordia study suggests that aquatic therapy for individuals with chronic low back pain can do more than strengthen the muscles around the spine.

17 Jun 2025

Combination therapy may improve health outcomes in adolescents with type 1 diabetes

A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney disease and improve health outcomes.

17 Jun 2025

Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to those who take weekly injections of GLP-1 anti-obesity medications, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, according to a new head-to-head real-world study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Could a diabetes drug be the key to stopping Alzheimer’s?

Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, linking diabetes and neurodegeneration.

17 Jun 2025

Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a breakthrough clinical trial application in place of a human placebo group, marking a world-first in lung disease research.

17 Jun 2025

Sphere Bio expands operations in China

Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today announced the appointment of Redbert Biotechnology (张伟) as its exclusive distribution partner in China.

17 Jun 2025

World Wellbeing Week: Bedfont® Scientific Limited highlights ongoing investment in employee wellbeing

World Wellbeing Week is a global awareness event recognized annually during the last week of June.

From Bedfont® Scientific Ltd 17 Jun 2025

Blood test detects early signs of liver transplant rejection

Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other complications.

17 Jun 2025

Breakthrough therapy targets aggressive bladder cancer variant

Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.

17 Jun 2025

First patient treated in international clinical trial for rare muscle-weakness disease

The first patient enrolled in a planned international clinical trial has been treated at HonorHealth Research Institute with a new type of immune therapy for those with a rare muscle-weakness disease known as Myasthenia Gravis.

16 Jun 2025

Researchers identify a new treatment strategy for neuroblastoma

Researchers at Karolinska Institutet and Lund University in Sweden have identified a new treatment strategy for neuroblastoma, an aggressive form of childhood cancer.

16 Jun 2025

New hereditary condition impairs DNA repair and raises blood cancer risk

A new hereditary condition has been discovered that affects patients' ability to repair DNA – leaving them both at greater risk of developing blood cancer, and unable to repair some of the damage caused by chemotherapy treatments.

16 Jun 2025

Two existing medications work effectively together in treating alcohol use disorder

Two existing medications - one used for smoking cessation and the other for depression - appear to work effectively together in treating alcohol use disorder.

16 Jun 2025

Night shift work increases risk of severe asthma in women

Women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime, according to a study published today (Monday) in ERJ Open Research.

16 Jun 2025

Solascure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational Aurase Wound Gel (AWG), in the treatment of patients with calciphylaxis ulcers.

16 Jun 2025

Indiana University researcher helps develop FDA-approved Alzheimer’s test

A first-of-its-kind blood test to detect amyloid plaques in the brain associated with Alzheimer's disease recently received clearance from the U.S. Food and Drug Administration. An Indiana University School of Medicine researcher who helped lead the discovery and development of one of the biomarkers the test identifies hopes it will provide greater access and a more accurate diagnosis for patients.

16 Jun 2025

A revolutionary drug for extreme hunger offers clues to obesity’s complexity

Ali Foley Shenk still remembers the panic when her 10-year-old son, Dean, finished a 20-ounce box of raisins in the seconds the cupboard was left unlocked. They rushed to the emergency room, fearing a dangerous bowel impaction.

16 Jun 2025

Therapy News and Research

OCCAM Immune and Cancer Research Institute join forces to advance immunotherapy

Colorectal cancer patients fare better when diagnosed before other cancers

Aquatic therapy eases back pain and boosts mental health

Combination therapy may improve health outcomes in adolescents with type 1 diabetes

Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Could a diabetes drug be the key to stopping Alzheimer’s?

Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Sphere Bio expands operations in China

World Wellbeing Week: Bedfont® Scientific Limited highlights ongoing investment in employee wellbeing

Blood test detects early signs of liver transplant rejection

Breakthrough therapy targets aggressive bladder cancer variant

First patient treated in international clinical trial for rare muscle-weakness disease

Researchers identify a new treatment strategy for neuroblastoma

New hereditary condition impairs DNA repair and raises blood cancer risk

Two existing medications work effectively together in treating alcohol use disorder

Night shift work increases risk of severe asthma in women

Solascure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers

Indiana University researcher helps develop FDA-approved Alzheimer’s test

A revolutionary drug for extreme hunger offers clues to obesity’s complexity

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News